Oct 19 (Reuters) - Seqiru
- SEQIRUS - CELL-BASED QIVC GOT POSITIVE OPINION FROM CHMP OF EMA FOR USE IN PEOPLE AGED 9 YEARS AND ABOVE
- SEQIRUS - PLANS TO LAUNCH VACCINE AS FLUCELVAX TETRA IN EUROPE FOR 2019/20 INFLUENZA SEASON
Oct 19 (Reuters) - Seqiru SEQIRUS - CELL-BASED QIVC GOT...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$296.00 |
Change
-0.690(0.23%) |
Mkt cap ! $143.3B | |||
| Open | High | Low | Value | Volume |
| $296.70 | $297.28 | $295.09 | $108.7M | 367.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 929 | $295.96 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $296.44 | 474 | 1 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| CSL (ASX) Chart |